1662.1 – The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques

Page last updated: 22 June 2022

Application Detail

Description of Medical Service

A catheter-based technique for the delivery of a permanent implant to the mitral valve via transeptal access. The implant clasps the anterior and posterior leaflets around a spacer, thus creating a double orifice and reducing mitral regurgitation (MR). The Implant System consists of the Steerable Catheter (outermost layer), the Implant Catheter (innermost layer), and the implant. The Implant System percutaneously delivers the implant to the valve via a femoral vein access using a transvenous, transeptal approach. The implant is deployed and secured to the leaflets of the valve, acting as a filler in the regurgitant orifice. The primary components of the Implant are the spacer, paddles, and clasps made from Nitinol. This Application refers to the proposed medical service as transcatheter mitral valve repair.

Description of Medical Condition

MR (also known as mitral insufficiency), is a condition in which incompetency of the mitral valve causes abnormal backflow of blood from the left ventricle to the left atrium during the systolic phase of the cardiac cycle. There are two types of MR: degenerative and functional. Degenerative mitral regurgitation, also known as primary MR, refers to regurgitation resulting from the structural abnormality of the mitral valve leaflets and/or valve apparatus. In contrast, functional mitral regurgitation, also known as secondary MR, occurs when the valve and/or valve apparatus is structurally normal, but dysfunction, distortion, or dilation of the left atrial or ventricular chambers results in tethering of the leaflets and/or mitral annular dilation. MR is associated with an increased risk for heart failure and death

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number/s

1662

Associated Documentation

Application Form

Application Form (PDF 1397 KB)
Application Form (Word 406 KB)

Consultation Survey

Consultation Survey (PDF 323 KB)
Consultation Survey (Word 72 KB)

MSAC Consultation
MSAC consultation input must be received by no later than Friday, 7 October 2022 for it to be considered by MSAC at its November 2022 meeting.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

Bypassing PASC

ESC

6-7 October 2022

MSAC

24-25 November 2022